S-1 maintenance therapy in Caucasian patients with metastatic esophagogastric adenocarcinoma–final results of the randomized AIO MATEO phase II trial-Reference-Cited by-同舟云学术

S-1 maintenance therapy in Caucasian patients with metastatic esophagogastric adenocarcinoma–final results of the randomized AIO MATEO phase II trial

Published:2023-06 Issue:3 Volume:8 Page:101572
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Stocker G.,Lorenzen S.,Ettrich T.,Herz A.-L.,Longo F.,Kiani A.,Venerito M.,Trojan J.,Mahlberg R.,Moosmann N.,Chibaudel B.,Kubicka S.,Greil R.,Daum S.,Geissler M.,Larcher-Senn J.,Keller G.,Lordick F.,Haag G.M.

Funder

MSD Sharp and Dohme

Nordic Pharma Group

Taiho Pharmaceutical

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference29 articles.

1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Predicting the future burden of esophageal cancer by histological subtype: international trends in incidence up to 2030;Arnold;Am J Gastroenterol,2017

3. International variation in oesophageal and gastric cancer survival 2012-2014: differences by histological subtype and stage at diagnosis (an ICBP SURVMARK-2 population-based study);Arnold;Gut,2022

4. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

5. Capecitabine and oxaliplatin for advanced esophagogastric cancer;Cunningham;N Engl J Med,2008

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Magic Flute is a Singspiel, not an opera? My thoughts about the German, Austrian and Swiss Guidelines for Systemic Treatment of Gastric Cancer;Gastric Cancer;2023-10-13

2. S-1 maintenance therapy in advanced gastric cancer without disease progression after first-line chemotherapy: A retrospective analysis;Science Progress;2023-10